These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26593415)

  • 1. Regulation of the Melanocortin-Sensitive Adenylate Cyclase System by N-Acylated Peptide 71-82 of Type 4 Melanocortin Receptor.
    Shpakov AO; Derkach KV; Shpakova EA
    Bull Exp Biol Med; 2015 Nov; 160(1):40-4. PubMed ID: 26593415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-palmitoylated peptide 232-245 of rat type 4 melanocortin receptor possessing agonistic activity].
    Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
    Tsitologiia; 2014; 56(8):604-11. PubMed ID: 25697006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of peptides corresponding to extracellular domains of serotonin 1B/1D receptors and melanocortin 3 and 4 receptors on hormonal regulation of adenylate cyclase in rat brain.
    Shpakova EA; Derkach KV; Shpakov AO
    Bull Exp Biol Med; 2014 Mar; 156(5):658-62. PubMed ID: 24770752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [THE THYROID STATUS OF RATS IMMUNIZED WITH PEPTIDES DERIVED FROM THE EXTRACELLULAR REGIONS OF THE TYPES 3 AND 4 MELANOCORTIN RECEPTORS AND THE 1B-SUBTYPE 5-HYDROXYTRYPTAMINE RECEPTOR].
    Derkach KV; Moyseuk IV; Shpakova EA; Sphakov AO
    Zh Evol Biokhim Fiziol; 2015; 51(4):243-50. PubMed ID: 26547948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the melanocortin 3 receptor in mediating the effects of gamma-MSH peptides on the adrenal.
    Harmer SC; Bicknell AB
    Endocr Res; 2004 Nov; 30(4):629-35. PubMed ID: 15666803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The secondary structure of peptides derived from the third intracellular loop of the serpentine type receptors and its interrelation with their biological activity].
    Shpakova EA; Skvortsova EA; Tarasenko II; Shpakov AO
    Tsitologiia; 2012; 54(2):119-29. PubMed ID: 22590924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors.
    Cragnolini AB; Perelló M; Schiöth HB; Scimonelli TN
    Regul Pept; 2004 Nov; 122(3):185-90. PubMed ID: 15491790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of adenylyl cyclase activity in the rat testes by acylated derivatives of peptide 562-572 of luteinizing hormone receptor].
    Shpakova EA; Shpakov AO
    Tsitologiia; 2013; 55(10):737-44. PubMed ID: 25509128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.
    Mioni C; Giuliani D; Cainazzo MM; Leone S; Bazzani C; Grieco P; Novellino E; Tomasi A; Bertolini A; Guarini S
    Eur J Pharmacol; 2003 Sep; 477(3):227-34. PubMed ID: 14522361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin-4 receptor in swamp eel (Monopterus albus): Cloning, tissue distribution, and pharmacology.
    Yi TL; Yang LK; Ruan GL; Yang DQ; Tao YX
    Gene; 2018 Dec; 678():79-89. PubMed ID: 30075196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of melanocortin-4 receptor agonists and antagonists on expression of genes related to reproduction in spotted scat, Scatophagus argus.
    Jiang DN; Li JT; Tao YX; Chen HP; Deng SP; Zhu CH; Li GL
    J Comp Physiol B; 2017 May; 187(4):603-612. PubMed ID: 28197776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.
    Muceniece R; Zvejniece L; Vilskersts R; Liepinsh E; Baumane L; Kalvinsh I; Wikberg JE; Dambrova M
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):416-20. PubMed ID: 18028105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.
    Caruso C; Carniglia L; Durand D; Gonzalez PV; Scimonelli TN; Lasaga M
    Mol Cell Endocrinol; 2012 Jan; 348(1):47-54. PubMed ID: 21803120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
    Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
    Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.